Context:

Florida reversed a sudden cut to its AIDS Drug Assistance Program, restoring access to life-sustaining HIV medications after an uproar and a lawsuit. A short-term funding package, approved by both chambers and signed by Gov. DeSantis, temporarily funds the program through June 30 and rolls back stricter enrollment rules that had left thousands vulnerable. The move came amid cost pressures from rising drug prices, flat federal funding, and a budget shortfall cited by health officials as justification for the initial restriction. While relief is immediate, lawmakers acknowledge the need for a longer-term solution to preserve uninterrupted treatment. The situation highlights the tension between budget constraints and access to essential care for people living with HIV.

Dive Deeper:

• A state health department restrictions on eligibility were enacted on March 1, triggering litigation and public demonstrations as advocates argued that lifesaving medications could become unaffordable for many patients.

• The legislature approved a $30.9 million, short-term funding bill to keep the program running through June 30, effectively restoring the prior, broader eligibility rules until a longer-term plan is devised.

• Governor Ron DeSantis signed the measure into law, with leaders from both parties framing the move as urgent, lifesaving policy action in response to immediate patient needs.

• Advocacy groups and legislators pointed to rising HIV drug costs, aging subsidies, and flat federal support as drivers of the previous tightening of eligibility that risked leaving patients without access to treatment.

• AIDS Drug Assistance Programs nationally cover a substantial share of HIV medications for many patients, and the Florida case mirrors broader debates about sustaining care amid fiscal pressures, while officials consider subsequent funding legislation beyond June.